CA-RECOVER
14.10.2021 16:07:08 CEST | Business Wire | Press release
Global fashion retailer REVOLVE has partnered with Recover™, leading producer in recycled cotton fiber, to introduce a sustainable denim collection with REVOLVE-owned brand Lovers and Friends.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211014005745/en/
Recover™ is an innovative textile fiber producer that has been pioneering sustainable materials and recycling since 1947. The company recycles post-industrial and post-consumer cotton waste, replacing the need to cultivate cotton, dramatically reducing water waste, limiting the use of dyes through its RColorBlend system, and reducing textile landfill waste.
Launched today, the range features 14 styles of jeans, each produced with a minimum of 15% Recover™ recycled cotton fiber made from post-consumer denim.
The pairing of the valuable resources Recover™ provides with Lovers and Friends underscores REVOLVE’s commitment to sustainable fashion, and leading the change towards a more circular, and enduring fashion system.
“REVOLVE has a responsibility to contribute positively to the longevity of our industry and ecosystem, and for us, this process begins at home. We have worked with thousands of brands and suppliers, and Recover™ is unparalleled in its expertise and long-term focus. We are proud to partner with this multigeneration, family-owned business to deliver the strongest messaging and product to our consumers with one of our most recognizable owned brands, Lovers and Friends.” - Michael Mente, Co-CEO and Co-Founder REVOLVE Group.
“It is great to launch this sustainable collection today with such an iconic American brand and denim product. By incorporating Recover´s lowest-impact, highest-quality recycled fiber into the Lovers and Friends denim line we have created a strong collaboration that is helping to bring sustainable fashion closer to the consumer. Recover™ aims to scale its recycled cotton fiber production to help more brands meet their sustainable goals and achieve circular fashion for all.” - Alfredo Ferre, CEO Recover™
Recover™ has already supplied its recycled cotton and cotton blend fibers to illustrious brands such as Wrangler, H&M Group, Tommy Hilfiger, G-Star, The North Face, Billabong and Primark among many others during its rich history.
“Recover™ is building a strong ingredient brand, with the mission to dramatically enhance the environmental value of the garment for the final customer. We’ve taken special care in the way we inform them about the impact of this collection in collaboration with REVOLVE. The hang tag includes a QR code that leads to more information about the environmental savings, such as water, and compares them to day-to-day activities, like the number of showers, to make them more understandable.” – Boris Mercier, Marketing Director Recover™
By adding REVOLVE and Lovers and Friends to its portfolio, Recover™ moves one step closer to achieving its mission of “circular fashion for all”.
Price Range: $128-$158. Available at REVOLVE.com
About Recover™
Recover™ is a leading material sciences company and global producer of low-impact, high-quality recycled cotton fiber and cotton fiber blends. Its premium, environmentally friendly, and cost-competitive products are created in partnership with the supply chain for global retailers and brands, offering a sustainable solution to achieve circular fashion for all.
As a fourth-generation, family-owned company with over a 70-year history in the textile industry, Recover™ is on a mission to scale its proprietary technology to make a lasting positive impact on the environment and partner with brands/retailers and other change-makers to meet the industry’s sustainability targets. Recover™ was honored in Fast Company ’s Innovation by Design Awards for 2021 in the Sustainability and Materials categories.
For more information, visit www.recoverfiber.com and follow @recoverfiber on social media.
About REVOLVE
REVOLVE is the next-generation fashion retailer for Millennial and Generation Z consumers. As a trusted, premium lifestyle brand and a go-to source for discovery and inspiration, REVOLVE delivers an engaging customer experience from a vast yet curated offering of over 45,000 products. Founded in Los Angeles in 2003 by co-CEOs, Michael Mente and Mike Karanikolas, REVOLVE’s family of brands includes their luxury offering, FWRD.com, and a portfolio of owned brands such as Lovers and Friends, Tularosa, NBD and RAYE. For more information, please visit www.revolve.com , or find us on Instagram , Twitter, Pinterest, and Facebook.
About Lovers and Friends
Inspired by the laid back Los Angeles lifestyle in which the brand was founded, Lovers and Friends exudes effortless style and wearability, creating a signature sexy-meets-chic look with a California-cool sensibility. Lovers and Friends is designed for the girl who is a go-getter and fun-seeker. Every trend-inspired outfit is perfectly curated for her event-filled social schedule, whether she's meeting her girls for brunch or jet-setting to another coast. Sometimes sassy, sometimes sweet but always chic - she is both a LOVER and a FRIEND.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005745/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 15:07:00 CEST | Press release
Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media’s stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™,
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release
First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
